Eun Sook Lee - 30 Apr 2025 Form 3 Insider Report for Liminatus Pharma, Inc. (LIMN)

Role
Director
Signature
/s/ Eun Sook Lee
Issuer symbol
LIMN
Transactions as of
30 Apr 2025
Net transactions value
$0
Form type
3
Filing time
01 May 2025, 06:00:54 UTC

No securities are beneficially owned.